BSBilal Çağdaş Seven

Bilal Çağdaş Seven

*This is an algorithmically generated author record based on publicly available information.

Bilal Çağdaş Seven has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Prognostic value of pre-transplant inflammatory and albumin-based composite ratios for pneumonia and mortality after allogeneic hematopoietic stem cell transplantation

    by Özlem Düvenci Birben, Esma Sevil Akkurt, Derya Yenibertiz, Bilal Çağdaş Seven, Tahir Darçın, Bahar Uncu Ulu, Dicle İsKender, Tuğçe Nur Yiğenoğlu, Mehmet Sinan Dal, Fevzi Altuntaş

    Aims: Patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) are highly susceptible to infectious complications due to immunosuppression and delayed immune reconstitution, with pneumonia remaining a major cause of early morbidity and mortality. Composite inflammation- and protein-based biomarkers, including the C-reactive protein-to-albumin ratio (CAR) and fibrinogen-to-albumin ratio (FAR), have prognostic value in oncology, but their role in predicting pneumonia and survival after allo-HSCT is unclear.Methods: This retrospective, single-center study included 203 adult allo-HSCT recipients treated between 2020 and 2023. Pre transplant inflammatory and protein-based biomarkers were assessed 7-14 days before transplantation, and Cox proportional hazards regression was used to identify independent predictors of one-year post-transplant pneumonia and mortality.Results: Pneumonia occurred in 17.7% of patients, and one-year mortality was 41.9%. Although lower albumin, hemoglobin, and platelet levels and higher procalcitonin (PCT) concentrations were associated with pneumonia in univariate analyses, no biomarker independently predicted post-transplant pneumonia after multivariate adjustment. In contrast, pre-transplant PCT (HR=1.020, p